277 related articles for article (PubMed ID: 26291811)
1. Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea.
Grandi G; Napolitano A; Xholli A; Tirelli A; Di Carlo C; Cagnacci A
Gynecol Endocrinol; 2015 Oct; 31(10):774-8. PubMed ID: 26291811
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of the effects of nomegestrol acetate/17 β-estradiol and drospirenone/ethinylestradiol on premenstrual and menstrual symptoms and dysmenorrhea.
Witjes H; Creinin MD; Sundström-Poromaa I; Martin Nguyen A; Korver T
Eur J Contracept Reprod Health Care; 2015; 20(4):296-307. PubMed ID: 25712537
[TBL] [Abstract][Full Text] [Related]
3. Body composition and psychological improvement in healthy premenopausal women assuming the oral contraceptive containing micronized estradiol (E2) and nomegestrol acetate (NOMAC).
Neri M; Malune ME; Corda V; Piras B; Zedda P; Pilloni M; Orani MP; Vallerino V; Melis GB; Paoletti AM
Gynecol Endocrinol; 2017 Dec; 33(12):958-962. PubMed ID: 28485628
[TBL] [Abstract][Full Text] [Related]
4. Pooled analysis of two randomized, open-label studies comparing the effects of nomegestrol acetate/17β-estradiol and drospirenone/ethinyl estradiol on bleeding patterns in healthy women.
Mansour D; Westhoff C; Kher U; Korver T
Contraception; 2017 Apr; 95(4):390-397. PubMed ID: 28011288
[TBL] [Abstract][Full Text] [Related]
5. Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. A double-blind, randomised study.
Gaussem P; Alhenc-Gelas M; Thomas JL; Bachelot-Loza C; Remones V; Ali FD; Aiach M; Scarabin PY
Thromb Haemost; 2011 Mar; 105(3):560-7. PubMed ID: 21225090
[TBL] [Abstract][Full Text] [Related]
6. Six-month evaluation of the benefits of the low-dose combined oral contraceptive chlormadinone acetate 2 mg/ethinylestradiol 0.03 mg in young women: results of the prospective, observational, non-interventional, multicentre TeeNIS study.
Anthuber S; Schramm GA; Heskamp ML
Clin Drug Investig; 2010; 30(4):211-20. PubMed ID: 20225905
[TBL] [Abstract][Full Text] [Related]
7. Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate/17β-estradiol in comparison to levonorgestrel/ethinylestradiol.
Sørdal T; Grob P; Verhoeven C
Acta Obstet Gynecol Scand; 2012 Nov; 91(11):1279-85. PubMed ID: 22762147
[TBL] [Abstract][Full Text] [Related]
8. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism.
Ågren UM; Anttila M; Mäenpää-Liukko K; Rantala ML; Rautiainen H; Sommer WF; Mommers E
Eur J Contracept Reprod Health Care; 2011 Dec; 16(6):444-57. PubMed ID: 22066891
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen.
Mansour D; Verhoeven C; Sommer W; Weisberg E; Taneepanichskul S; Melis GB; Sundström-Poromaa I; Korver T
Eur J Contracept Reprod Health Care; 2011 Dec; 16(6):430-43. PubMed ID: 21995590
[TBL] [Abstract][Full Text] [Related]
10. A phase 2b multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of vaginal rings containing nomegestrol acetate or etonogestrel and 17β-estradiol in the treatment of women with primary dysmenorrhea.
Fox MC; Klipping C; Nguyen AM; Frenkl TL; Cruz SM; Wang Y; Korver T
Contraception; 2019 Feb; 99(2):125-130. PubMed ID: 30439359
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of efficacy, safety and effects on symptoms of androgenization of a generic oral contraceptive containing chlormadinone acetate 2 mg/ethinylestradiol 0.03 mg.
Hadji P; Biskup J; Boekhoff J; Ziller M; Bonn M; Rovati L
Contraception; 2012 Oct; 86(4):359-65. PubMed ID: 22445436
[TBL] [Abstract][Full Text] [Related]
12. Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol.
Grandi G; Piacenti I; Volpe A; Cagnacci A
Gynecol Endocrinol; 2014 Sep; 30(9):676-80. PubMed ID: 24918262
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen.
Brucker C; Hedon B; The HS; Höschen K; Binder N; Christoph A
Contraception; 2010 Jun; 81(6):501-9. PubMed ID: 20472117
[TBL] [Abstract][Full Text] [Related]
14. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
Winkler UH; Sudik R
Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436
[TBL] [Abstract][Full Text] [Related]
15. Switching hormonal contraceptives to a chlormadinone acetate-containing oral contraceptive. The Contraceptive Switch Study.
Schramm G; Heckes B
Contraception; 2007 Aug; 76(2):84-90. PubMed ID: 17656175
[TBL] [Abstract][Full Text] [Related]
16. Nomegestrol acetate/17beta-estradiol does not negatively alter the vascular resistance of clitoral arteries: a prospective, exploratory study.
Scavello I; Maseroli E; Di Stasi V; Cipriani S; Verde N; Magini A; Maggi M; Vignozzi L
Int J Impot Res; 2020 Mar; 32(2):239-247. PubMed ID: 31263248
[TBL] [Abstract][Full Text] [Related]
17. Safety data and beneficial effects of the combined oral contraceptive ethinylestradiol 0.03 mg/chlormadinone acetate 2 mg (Belara®): a 13-cycle, observational study in routine clinical practice.
Pushparajah DS; Röhm P; Höschen K; Albers D; Nowack C
Clin Drug Investig; 2011; 31(2):121-34. PubMed ID: 21155614
[TBL] [Abstract][Full Text] [Related]
18. Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17β-estradiol (NOMAC/E2): a double-blind, randomized study.
Christin-Maitre S; Serfaty D; Chabbert-Buffet N; Ochsenbein E; Chassard D; Thomas JL
Hum Reprod; 2011 Jun; 26(6):1338-47. PubMed ID: 21421664
[TBL] [Abstract][Full Text] [Related]
19. Does Nomegestrol Acetate Plus 17β-Estradiol Oral Contraceptive Improve Endometriosis-Associated Chronic Pelvic Pain in Women?
Caruso S; Cianci A; Iraci M; Fava V; Di Pasqua S; Cianci S
J Womens Health (Larchmt); 2020 Sep; 29(9):1184-1191. PubMed ID: 32678691
[No Abstract] [Full Text] [Related]
20. Comparison of the effects of chlormadinone acetate versus drospirenone containing oral contraceptives on metabolic and hormonal parameters in women with PCOS for a period of two-year follow-up.
Yildizhan R; Gokce AI; Yildizhan B; Cim N
Gynecol Endocrinol; 2015 May; 31(5):396-400. PubMed ID: 25739031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
